Appointment booking for Dr. Michael Keller, MD is currently not available.Dr. Michael Keller, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Michael Keller, MD (he/him) is a Rheumatologist in San Diego, CA with over 18 years of experience. What is your opinion of Dr. Michael Keller, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Keller, MD has received over $20,588 which includes payments from the following companies:
$3,705.62 from Amgen Inc.
$2,574.45 from Pfizer Inc.
$1,277.33 from AbbVie, Inc.
$1,207.74 from Novartis Pharmaceuticals Corporation
$1,107.46 from E.R. Squibb & Sons, L.L.C.
$1,052.94 from Mallinckrodt LLC
$1,009.70 from Celgene Corporation
$960.70 from Genentech USA, Inc.
$889.79 from Purdue Pharma L.P.
$732.09 from Horizon Pharma plc
$725.45 from GlaxoSmithKline, LLC.
$571.91 from LILLY USA, LLC
$532.27 from UCB, Inc.
$471.67 from Questcor Pharmaceuticals
$448.93 from MEDAC PHARMA, INC.
$396.76 from Janssen Biotech, Inc.
$360.55 from Mallinckrodt Enterprises LLC
$280.63 from Antares Pharma, Inc.
$231.87 from Gilead Sciences Inc
$210.07 from Iroko Pharmaceuticals, LLC
Payments received by Dr. Michael Keller, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!